Target Healthcare REIT (LON:THRL – Get Free Report)’s stock price reached a new 52-week high during trading on Wednesday . The company traded as high as GBX 108.80 and last traded at GBX 105.80, with a volume of 963337 shares trading hands. The stock had previously closed at GBX 106.60.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group upped their price target on Target Healthcare REIT from GBX 99 to GBX 101 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. One analyst has rated the stock with a Buy rating, According to MarketBeat, Target Healthcare REIT presently has an average rating of “Buy” and a consensus target price of GBX 101.
Check Out Our Latest Stock Analysis on THRL
Target Healthcare REIT Trading Up 0.2%
Target Healthcare REIT Company Profile
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Featured Articles
- Five stocks we like better than Target Healthcare REIT
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- This makes me furious
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
